Advertisement

Table of Contents

August 01, 1988; Volume 34,Issue 2

You have access
Characterization of the omega-conotoxin-binding molecule in rat brain synaptosomes and cultured neurons.
B Marqueze, N Martin-Moutot, C Levêque and F Couraud

Molecular Pharmacology August 1988, 34 (2) 87-90;
You have access
Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
K R Jarvie, H B Niznik and P Seeman

Molecular Pharmacology August 1988, 34 (2) 91-97;
You have access
Voltage-dependent block by strychnine of N-methyl-D-aspartic acid-activated cationic channels in rat cortical neurons in culture.
M Bertolino and S Vicini

Molecular Pharmacology August 1988, 34 (2) 98-103;
You have access
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
M H el Kouni, F N Naguib, S H Chu, S M Cha, T Ueda, G Gosselin, J L Imbach, Y F Shealy and B A Otter

Molecular Pharmacology August 1988, 34 (2) 104-110;
You have access
Effects of guanine nucleotides on N-methyl-D-aspartate receptor-ligand interactions.
J B Monahan, W F Hood, J Michel and R P Compton

Molecular Pharmacology August 1988, 34 (2) 111-116;
You have access
Effects of thiol-reagents on [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes.
T Terramani, M Kessler, G Lynch and M Baudry

Molecular Pharmacology August 1988, 34 (2) 117-123;
You have access
In vivo binding of beta-carbolines in mice: regional differences and correlation of occupancy to pharmacological effects.
M C Potier, L Prado de Carvalho, R H Dodd, R Besselievre and J Rossier

Molecular Pharmacology August 1988, 34 (2) 124-128;
You have access
Benzodiazepine interactions with GABAA receptors on chick ciliary ganglion neurons.
A E McEachern and D K Berg

Molecular Pharmacology August 1988, 34 (2) 129-135;
You have access
Polyclonal and monoclonal antibodies directed against SK & F 94461, a specific H1 histamine receptor ligand.
L Chatenoud, F Villemain, J Hoebeke, M Garbarg, M Korner, C Gros, M Ruat, P A Cazenave, C R Ganellin and J F Bach

Molecular Pharmacology August 1988, 34 (2) 136-144;
You have access
High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
L Tahraoui, A Floch, S Mondot and I Cavero

Molecular Pharmacology August 1988, 34 (2) 145-151;
You have access
Four polypeptide components of green mamba venom selectively block certain potassium channels in rat brain synaptosomes.
C G Benishin, R G Sorensen, W E Brown, B K Krueger and M P Blaustein

Molecular Pharmacology August 1988, 34 (2) 152-159;
You have access
Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
U Kragh-Hansen

Molecular Pharmacology August 1988, 34 (2) 160-171;
You have access
Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (+/-)-verapamil in living cardiac cells.
H Porzig and C Becker

Molecular Pharmacology August 1988, 34 (2) 172-179;
You have access
The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells.
W D Klohs and R W Steinkampf

Molecular Pharmacology August 1988, 34 (2) 180-185;
You have access
Prostaglandin hydroperoxidase-dependent oxidation of phenylbutazone: relationship to inhibition of prostaglandin cyclooxygenase.
M F Hughes, R P Mason and T E Eling

Molecular Pharmacology August 1988, 34 (2) 186-193;
You have access
Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets.
J A Heroux and J A Roth

Molecular Pharmacology August 1988, 34 (2) 194-199;
You have access
Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
C M Lin, S B Singh, P S Chu, R O Dempcy, J M Schmidt, G R Pettit and E Hamel

Molecular Pharmacology August 1988, 34 (2) 200-208;
You have access
Liver membrane calcium transport in diquat-induced oxidative stress in vivo.
J O Tsokos-Kuhn, C V Smith, H Hughes and J R Mitchell

Molecular Pharmacology August 1988, 34 (2) 209-214;
You have access
The non-human primate: a possible model for human genetically determined polymorphisms in oxidative drug metabolism.
E Jacqz, C Billante, F Moysan and H Mathieu

Molecular Pharmacology August 1988, 34 (2) 215-217;
You have access
Computer-automated structure evaluation of flavonoids and other structurally related compounds as glyoxalase I enzyme inhibitors.
G Klopman and M L Dimayuga

Molecular Pharmacology August 1988, 34 (2) 218-222;
You have access
Metabolites and DNA adduct formation from flavoenzyme-activated porfiromycin.
S S Pan and T Iracki

Molecular Pharmacology August 1988, 34 (2) 223-228;
You have access
Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin.
C A Bradfield, A S Kende and A Poland

Molecular Pharmacology August 1988, 34 (2) 229-237;